2022 Universal Registration Document

Loading...

Recent search criteria

  • Media  arrow_down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investors  arrow_down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Reports and Accounts
    • Regulated Information
  • Partnering
  • Careers  arrow_down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture

  • Loading...
  • English  EN     Français  FR     EN  arrow_down
    • EnglishEN
    • FrançaisFR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada EN
    • Canada FR
    • Australia
    • China
    • Singapore
    • South Korea
    • Belgium FR
    • Belgium NL
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
  • Home
  • Company  arrow_down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Science  arrow_down
      < Back
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibility  arrow_down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients  arrow_down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  1. Home
  2. Annual reports
  3. annual reports

2022 Universal Registration Document

Back

Post navigation

Previous
Next

2022 Universal Registration Document

This registration document contains forward-looking statements about the Group’s targets and forecasts, including the Annual Financial Report.

2022 Universal Registration Document

- 06 April 2023 - 1 mins read

This registration document contains forward-looking statements about the Group’s targets and forecasts, including the Annual Financial Report.

Post navigation

Previous
Next

Share this on social media

  • Share on LinkedIn
  • Share on Twitter
  • Share on Facebook

Related Documents

  • Download Universal Registration Document   Download  (11 MB)

Related Annual reports

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023
02 June 2023 0 mins read

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023
01 June 2023 0 mins read

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023

2022 Integrated Annual Report
31 May 2023 1 mins read

2022 Integrated Annual Report

Generation Ipsen – for positive change
24 April 2023 1 mins read

Generation Ipsen – for positive change

Ipsen in Brief
24 April 2023 1 mins read

Ipsen in Brief

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer
09 February 2023 0 mins read

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer

2021 Integrated Annual Report
31 May 2022 0 mins read

2021 Integrated Annual Report

Information relating to compensation elements
25 May 2022 0 mins read

Information relating to compensation elements

Compensation policy for corporate officers, result of vote SM
25 May 2022 0 mins read

Compensation policy for corporate officers, result of vote SM

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer
14 May 2022 0 mins read

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer

IPN price

€103.20

 €-0.70 (-0.67%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us

Latest_Ipsen logo
LinkedInTwitterFacebookInstagramYoutube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2023

You are now leaving the Ipsen group website.To continue, please click on Continue?